|
End-of-day quote
Bulgaria S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 2.590 EUR | +0.39% |
|
+3.60% | +81.81% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.64B 1.59B 1.39B 1.32B 1.2B 2.25B 152B 2.26B 15.79B 6.1B 77.66B 5.95B 5.82B 250B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.18B 1.91B 1.68B 1.59B 1.44B 2.71B 183B 2.72B 19.03B 7.35B 93.59B 7.17B 7.02B 301B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +0.39% | ||
| 1 week | +3.60% | ||
| Current month | +14.10% | ||
| 1 month | +18.26% | ||
| 3 months | +34.20% | ||
| 6 months | +45.92% | ||
| Current year | +81.81% |
| 1 week | 2.46 |  | 2.59 |
| 1 month | 2.2 | | 2.59 |
| Current year | 1.41 | | 2.59 |
| 1 year | 1.34 | | 2.59 |
| 3 years | 0.94 | | 2.59 |
| 5 years | 0.64 | | 2.59 |
| 10 years | 0.41 | | 2.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 2000-09-30 |
Boris Borisov
DFI | Director of Finance/CFO | - | 2001-12-31 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 2010-05-18 |
| Director/Board Member | 63 | 2010-05-18 | |
| Director/Board Member | 61 | 2011-07-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 9/30/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 9/29/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | +3.60% | +87.63% | +117.06% | 1.58B | |
| +2.76% | +0.94% | -45.50% | -10.20% | 14.26B | |
| -1.02% | -3.58% | -19.28% | -9.18% | 6.3B | |
| +1.06% | +0.88% | -56.12% | -41.19% | 5.82B | |
| +1.77% | +1.44% | -9.47% | -23.11% | 3.99B | |
| -0.38% | -1.62% | -19.86% | -36.75% | 3.17B | |
| +1.04% | +3.25% | -39.97% | -16.71% | 3.02B | |
| +1.25% | -1.00% | +3.86% | -29.34% | 2.98B | |
| -1.14% | -7.74% | +56.63% | - | 2.61B | |
| -2.02% | -2.01% | -29.89% | -14.22% | 2.32B | |
| Average | +0.35% | -1.26% | -7.20% | -7.07% | 4.61B | |
| Weighted average by Cap. | +0.92% | -2.11% | -23.66% | -14.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.13B 1.07B 969M 1.82B 123B 1.83B 12.8B 4.94B 62.94B 4.82B 4.72B 202B | 2.63B 1.58B 1.39B 1.32B 1.19B 2.24B 152B 2.25B 15.75B 6.08B 77.45B 5.94B 5.81B 249B |
| Net income | 77.85M 46.75M 41.12M 38.88M 35.27M 66.24M 4.49B 66.62M 466M 180M 2.29B 176M 172M 7.36B | 134M 80.19M 70.53M 66.69M 60.49M 114M 7.7B 114M 799M 308M 3.93B 301M 295M 12.62B |
| Net Debt | 444M 267M 235M 222M 201M 378M 25.61B 380M 2.66B 1.03B 13.07B 1B 980M 41.99B | 541M 325M 286M 270M 245M 461M 31.21B 463M 3.24B 1.25B 15.92B 1.22B 1.19B 51.17B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | €2.590 | +0.39% | 90,466 |
| 26-09-25 | €2.580 | +0.78% | 25,000 |
| 26-09-24 | €2.560 | +4.07% | 80,530 |
| 26-09-23 | €2.460 | -1.60% | 3,858 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
